{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:55:46Z","timestamp":1790848546006,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672405"],"award-info":[{"award-number":["81672405"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key project of Natural Science Foundation of Guangdong Province, China","award":["4210016041"],"award-info":[{"award-number":["4210016041"]}]},{"name":"Science and Technology Program of Guangzhou, China","award":["4250016043"],"award-info":[{"award-number":["4250016043"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.1007\/s13402-018-0410-8","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T07:33:11Z","timestamp":1538379191000},"page":"81-92","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K\/Akt pathway in gallbladder cancer"],"prefix":"10.1007","volume":"42","author":[{"given":"Zhenyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaorong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-4425","authenticated-orcid":false,"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"410_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"A.X. Zhu, T.S. Hong, A.F. Hezel, D.A. Kooby, Current management of gallbladder carcinoma. Oncologist 15, 168\u2013181 (2010)","journal-title":"Oncologist"},{"key":"410_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.5009\/gnl15080","volume":"10","author":"W Jung","year":"2016","unstructured":"W. Jung, J.Y. Jang, M.J. Kang, Y.R. Chang, Y.C. Shin, J. Chang, S.W. Kim, Effects of surgical methods and tumor location on survival and recurrence patterns after curative resection in patients with T2 gallbladder cancer. Gut Liver 10, 140\u2013146 (2016)","journal-title":"Gut Liver"},{"key":"410_CR3","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"R. Hundal, E.A. Shaffer, Gallbladder cancer: Epidemiology and outcome. Clin Epidemiol 6, 99\u2013109 (2014)","journal-title":"Clin Epidemiol"},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.canlet.2013.08.034","volume":"345","author":"Y Li","year":"2014","unstructured":"Y. Li, J. Zhang, H. Ma, Chronic inflammation and gallbladder cancer. Cancer Lett 345, 242\u2013248 (2014)","journal-title":"Cancer Lett"},{"key":"410_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","volume":"21","author":"XS Wu","year":"2014","unstructured":"X.S. Wu, L.B. Shi, M.L. Li, Q. Ding, H. Weng, W.G. Wu, Y. Cao, R.F. Bao, Y.J. Shu, Q.C. Ding, J.S. Mu, J. Gu, P. Dong, Y.B. Liu, Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol 21, 449\u2013457 (2014)","journal-title":"Ann Surg Oncol"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"S.M. Crusz, F.R. Balkwill, Inflammation and cancer: Advances and new agents. Nat Rev Clin Oncol 12, 584\u2013596 (2015)","journal-title":"Nat Rev Clin Oncol"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.immuni.2011.09.006","volume":"35","author":"A Kuraishy","year":"2011","unstructured":"A. Kuraishy, M. Karin, S.I. Grivennikov, Tumor promotion via injury- and death-induced inflammation. Immunity 35, 467\u2013477 (2011)","journal-title":"Immunity"},{"key":"410_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13402-018-0388-2","volume":"41","author":"P Nilendu","year":"2018","unstructured":"P. Nilendu, S.C. Sarode, D. Jahagirdar, I. Tandon, S. Patil, G.S. Sarode, J.K. Pal, N.K. Sharma, Mutual concessions and compromises between stromal cells and cancer cells: Driving tumor development and drug resistance. Cell Oncol 41, 353\u2013367 (2018)","journal-title":"Cell Oncol"},{"key":"410_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13402-018-0373-9","volume":"41","author":"IA Voutsadakis","year":"2018","unstructured":"I.A. Voutsadakis, Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: Therapeutic implications. Cell Oncol 41, 107\u2013121 (2018)","journal-title":"Cell Oncol"},{"key":"410_CR10","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/cas.12825","volume":"106","author":"S Oguro","year":"2015","unstructured":"S. Oguro, Y. Ino, K. Shimada, Y. Hatanaka, Y. Matsuno, M. Esaki, S. Nara, Y. Kishi, T. Kosuge, N. Hiraoka, Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer. Cancer Sci 106, 1750\u20131760 (2015)","journal-title":"Cancer Sci"},{"key":"410_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"S. Su, Q. Liu, J. Chen, J. Chen, F. Chen, C. He, D. Huang, W. Wu, L. Lin, W. Huang, Z. J, X. Cui, F. Zheng, H. Li, H. Yao, F. Su, E. Song, A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 25, 605\u2013620 (2014)","journal-title":"Cancer Cell"},{"key":"410_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"X. Ye, R.A. Weinberg, Epithelial-mesenchymal plasticity: A central regulator of cancer progression. Trends Cell Biol 25, 675\u2013686 (2015)","journal-title":"Trends Cell Biol"},{"key":"410_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","volume":"62","author":"OW Yeung","year":"2015","unstructured":"O.W. Yeung, C.M. Lo, C.C. Ling, X. Qi, W. Geng, C.X. Li, K.T. Ng, S.J. Forbes, X.Y. Guan, R.T. Poon, S.T. Fan, K. Man, Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol 62, 607\u2013616 (2015)","journal-title":"J Hepatol"},{"key":"410_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/labinvest.2013.69","volume":"93","author":"CY Liu","year":"2013","unstructured":"C.Y. Liu, J.Y. Xu, X.Y. Shi, W. Huang, T.Y. Ruan, P. Xie, J.L. Ding, M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway. Lab Investig 93, 844\u2013854 (2013)","journal-title":"Lab Investig"},{"key":"410_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"T. Kitamura, B.Z. Qian, J.W. Pollard, Immune cell promotion of metastasis. Nat Rev Immunol 15, 73\u201386 (2015)","journal-title":"Nat Rev Immunol"},{"key":"410_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"J. Chen, Y. Yao, C. Gong, F. Yu, S. Su, J. Chen, B. Liu, H. Deng, F. Wang, L. Lin, H. Yao, F. Su, K.S. Anderson, Q. Liu, M.E. Ewen, X. Yao, E. Song, CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19, 541\u2013555 (2011)","journal-title":"Cancer Cell"},{"key":"410_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","volume":"16","author":"SY Lee","year":"2017","unstructured":"S.Y. Lee, E.K. Jeong, M.K. Ju, H.M. Jeon, M.Y. Kim, C.H. Kim, H.G. Park, S.I. Han, H.S. Kang, Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 16, 10 (2017)","journal-title":"Mol Cancer"},{"key":"410_CR18","doi-asserted-by":"publisher","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"L. Larue, A. Bellacosa, Epithelial-mesenchymal transition in development and cancer: Role of phosphatidylinositol 3' kinase\/AKT pathways. Oncogene 24, 7443\u20137454 (2005)","journal-title":"Oncogene"},{"key":"410_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, P. Allavena, Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14, 399\u2013416 (2017)","journal-title":"Nat Rev Clin Oncol"},{"key":"410_CR20","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"J.A. Espinoza, C. Bizama, P. Garc\u00eda, C. Ferreccio, M. Javle, J.F. Miquel, J. Koshiol, J.C. Roa, The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 1865, 245\u2013254 (2016)","journal-title":"Biochim Biophys Acta"},{"key":"410_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"R. Noy, J.W. Pollard, Tumor-associated macrophages: From mechanisms to therapy. Immunity 41, 49\u201361 (2014)","journal-title":"Immunity"},{"key":"410_CR22","first-page":"514","volume":"l5","author":"P Italiani","year":"2014","unstructured":"P. Italiani, D. Boraschi, From monocytes to M1\/M2 macrophages: Phenotypical vs. functional differentiation. Front Immuno l5, 514 (2014)","journal-title":"Front Immuno"},{"key":"410_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13402-017-0337-5","volume":"40","author":"LM Nusblat","year":"2017","unstructured":"L.M. Nusblat, M.J. Carroll, C.M. Roth, Crosstalk between M2 macrophages and glioma stem cells. Cell Oncol 40, 471\u2013482 (2017)","journal-title":"Cell Oncol"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"C. Ngambenjawong, H.H. Gustafson, S.H. Pun, Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 114, 206\u2013221 (2017)","journal-title":"Adv Drug Deliv Rev"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nrc3428","volume":"13","author":"GK Alderton","year":"2013","unstructured":"G.K. Alderton, Metastasis: Epithelial to mesenchymal and back again. Nat Rev Cancer 13, 3 (2013)","journal-title":"Nat Rev Cancer"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"M. Suarez-Carmona, J. Lesage, D. Cataldo, C. Gilles, EMT and inflammation: Inseparable actors of cancer progression. Mol Oncol 11, 805\u2013823 (2017)","journal-title":"Mol Oncol"},{"key":"410_CR27","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-16-2706","volume":"77","author":"D Huang","year":"2017","unstructured":"D. Huang, S.J. Song, Z.Z. Wu, W. Wu, X.Y. Cui, J.N. Chen, M.S. Zeng, S.C. Su, Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Res 77, 3591\u20133604 (2017)","journal-title":"Cancer Res"},{"key":"410_CR28","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s13277-015-4172-x","volume":"37","author":"Z Lin","year":"2016","unstructured":"Z. Lin, W. Li, H. Zhang, W. Wu, Y. Peng, Y. Zeng, Y. Wan, J. Wang, N. Ouyang, CCL18\/PITPNM3 enhances migration, invasion, and EMT through the NF-kappaB signaling pathway in hepatocellular carcinoma. Tumour Biol 37, 3461\u20133468 (2016)","journal-title":"Tumour Biol"},{"key":"410_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jss.2013.01.017","volume":"183","author":"R Yuan","year":"2013","unstructured":"R. Yuan, Y. Chen, X. He, X. Wu, J. Ke, Y. Zou, Z. Cai, Y. Zeng, L. Wang, J. Wang, X. Fan, X. Wu, P. Lan, CCL18 as an independent favorable prognostic biomarker in patients with colorectal cancer. J Surg Res 183, 163\u2013169 (2013)","journal-title":"J Surg Res"}],"updated-by":[{"DOI":"10.1007\/s13402-022-00679-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-018-0410-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0410-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-018-0410-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T13:41:45Z","timestamp":1662039705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-018-0410-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,15]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1007\/s13402-018-0410-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s13402-022-00679-4","asserted-by":"object"}]},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"19 September 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13402-022-00679-4","URL":"https:\/\/doi.org\/10.1007\/s13402-022-00679-4","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the Institutional Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}